 A Loes score of 0.5 or less is classified as normal, while a Loes score of 14 or greater is considered severe.It was developed by neuroradiologist Daniel J. Loes MD and is an important tool in assessing disease progression and the effectiveness of therapy.Initial attempts at dietary therapy in ALD involved restricting the intake of very-long chain fatty acids (VLCFA).